Seek Returns

MDLN vs. PODD: Medline vs. Insulet Stock Comparison

How do Medline (MDLN) and Insulet (PODD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Medline (MDLN) and Insulet (PODD) both belong to the Health Care Equipment & Supplies industry, though MDLN is classified under Health Care Supplies while PODD falls under Health Care Equipment.

Insulet (PODD) has been public since May 15, 2007 with a meaningfully longer listed history, while Medline (MDLN) only listed on December 17, 2025 — long-window metrics on the MDLN side should be interpreted with caution.

Company profile comparison for Medline (MDLN) and Insulet (PODD)
Profile ItemMDLNPODD
NameMedline Inc. Class A Common StockInsulet Corporation
Country/RegionUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS Industry GroupHealth Care Equipment & ServicesHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & SuppliesHealth Care Equipment & Supplies
GICS Sub-IndustryHealth Care SuppliesHealth Care Equipment
Market Capitalization52.17 billion USD10.16 billion USD
CurrencyUSDUSD
ExchangeNasdaqNasdaq
Listing DateDecember 17, 2025May 15, 2007
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

MDLN
PODD
GSPC
Loading price history…
Medline (MDLN) vs. Insulet (PODD), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Medline (MDLN) and Insulet (PODD). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Medline (MDLN) and Insulet (PODD). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Medline (MDLN) and Insulet (PODD)
MetricMDLNPODD
Total Return (1Y)---53.25%
Total Return (3Y, Annualized)---0.74%
Total Return (5Y, Annualized)---14.02%

Risk Profile

Drawdown History

MDLN
PODD
GSPC
Loading price history…
Medline (MDLN) vs. Insulet (PODD), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Medline (MDLN) and Insulet (PODD). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Medline (MDLN) reports a negative beta of -0.93, suggesting inverse market sensitivity over the measurement window. That is uncommon for ordinary equities and can reflect commodity-linked or hedge-like exposure, but it can also come from statistical noise. Insulet (PODD) has a non-negative beta of 1.04.

Risk profile metrics for Medline (MDLN) and Insulet (PODD)
MetricMDLNPODD
Volatility (1Y, Annualized)47.93%46.33%
Beta (5Y)-0.931.04
Max Drawdown (5Y)-36.71%-63.02%
Avg. Volume (3M)8.63M1.58M

Risk-Adjusted Performance

Risk-Return Positioning

Both MDLN and PODD need 1-year volatility and 1-year return to plot risk-return positioning.

Risk-Adjusted Metrics

Risk-adjusted metrics for Medline (MDLN) and Insulet (PODD)
MetricMDLNPODD
Sharpe Ratio (1Y)---1.24
Sortino Ratio (1Y)---1.51

Profitability

ROE (TTM)

Insulet (PODD) at 28.94% sits in the top ROE quartile, while Medline (MDLN) at 4.85% is closer to the peer norm — stronger capital efficiency for PODD.

MDLN

Health Care Equipment & Services industry group

4.85%

Max
47.61%
Q3
14.36%
Median
5.45%
MDLN
4.85%
Q1
-10.67%
Min
-47.01%

PODD

Health Care Equipment & Services industry group

28.94%

Max
47.61%
PODD
28.94%
Q3
14.36%
Median
5.45%
Q1
-10.67%
Min
-47.01%
Loading chart…
Medline (MDLN) vs. Insulet (PODD): A comparison of their ROE against the Health Care Equipment & Services industry group benchmark.

Net Margin (TTM)

Insulet (PODD) at 13.44% retains a top-quartile share of revenue as profit, ahead of Medline (MDLN) at 1.85%, which keeps about the industry-typical share.

MDLN

Health Care Equipment & Services industry group

1.85%

Max
29.35%
Q3
9.33%
Median
2.18%
MDLN
1.85%
Q1
-6.29%
Min
-28.46%

PODD

Health Care Equipment & Services industry group

13.44%

Max
29.35%
PODD
13.44%
Q3
9.33%
Median
2.18%
Q1
-6.29%
Min
-28.46%
Loading chart…
Medline (MDLN) vs. Insulet (PODD): A comparison of their net margin against the Health Care Equipment & Services industry group benchmark.

Operating Margin (TTM)

Insulet (PODD) at 22.54% operates in the top operating margin quartile, ahead of Medline (MDLN) at 5.22%, which runs around its industry’s norm.

MDLN

Health Care Equipment & Services industry group

5.22%

Max
35.43%
Q3
14.14%
Median
6.81%
MDLN
5.22%
Q1
-0.28%
Min
-16.29%

PODD

Health Care Equipment & Services industry group

22.54%

Max
35.43%
PODD
22.54%
Q3
14.14%
Median
6.81%
Q1
-0.28%
Min
-16.29%
Loading chart…
Medline (MDLN) vs. Insulet (PODD): A comparison of their operating margin against the Health Care Equipment & Services industry group benchmark.

Profitability Metrics

Profitability metrics for Medline (MDLN) and Insulet (PODD)
MetricMDLNPODD
ROE (TTM)4.85%28.94%
ROA (TTM)2.70%11.40%
Net Margin (TTM)1.85%13.44%
Operating Margin (TTM)5.22%22.54%
Gross Margin (TTM)24.42%71.88%

Growth

Revenue Growth

Only one side can be read here: Insulet (PODD) reports revenue growth of 30.73%, ranked against its industry; Medline (MDLN) has no revenue growth figure this period.

Loading chart…
Medline (MDLN) vs. Insulet (PODD): A comparison of their Revenue Growth across different time periods.

EPS Growth

Medline (MDLN) at 117.38% delivers above-range EPS growth, while Insulet (PODD) at -39.79% falls into the bottom quartile — a wide split in earnings momentum.

Loading chart…
Medline (MDLN) vs. Insulet (PODD): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Medline (MDLN) and Insulet (PODD)
MetricMDLNPODD
Revenue Growth (YoY)--30.73%
Revenue Growth (3Y CAGR)--27.54%
EPS Growth (YoY)117.38%-39.79%
EPS Growth (3Y CAGR)--267.70%

Financial Strength

Current Ratio (MRQ)

Insulet (PODD) at 2.51 keeps current ratio within its industry’s typical mid-range, while Medline (MDLN) at 4.04 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.

MDLN

Health Care Equipment & Services industry group

4.04

Max
7.59
MDLN
4.04
Q3
4.00
Median
1.98
Q1
1.37
Min
0.30

PODD

Health Care Equipment & Services industry group

2.51

Max
7.59
Q3
4.00
PODD
2.51
Median
1.98
Q1
1.37
Min
0.30
Loading chart…
Medline (MDLN) vs. Insulet (PODD): A comparison of their current ratio against the Health Care Equipment & Services industry group benchmark.

Debt / Equity (MRQ)

Both Medline (MDLN) at 0.65 and Insulet (PODD) at 0.66 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

MDLN

Health Care Equipment & Services industry group

0.65

Max
1.88
Q3
0.91
MDLN
0.65
Median
0.58
Q1
0.16
Min
0.00

PODD

Health Care Equipment & Services industry group

0.66

Max
1.88
Q3
0.91
PODD
0.66
Median
0.58
Q1
0.16
Min
0.00
Loading chart…
Medline (MDLN) vs. Insulet (PODD): A comparison of their debt-to-equity ratio against the Health Care Equipment & Services industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Medline (MDLN) and Insulet (PODD)
MetricMDLNPODD
Current Ratio (MRQ)4.042.51
Debt / Equity (MRQ)0.650.66
Net Debt / EBITDA3.350.65

Dividends

Dividend Yield (TTM)

Neither Medline (MDLN) nor Insulet (PODD) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

MDLN

Health Care Equipment & Services industry group

0.00%

MDLN
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

PODD

Health Care Equipment & Services industry group

0.00%

PODD
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Medline (MDLN) vs. Insulet (PODD): A comparison of their dividend yield against the Health Care Equipment & Services industry group benchmark.

Dividend Payout Ratio (TTM)

Neither Medline (MDLN) nor Insulet (PODD) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

MDLN

Health Care Equipment & Services industry group

0.00%

MDLN
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

PODD

Health Care Equipment & Services industry group

0.00%

PODD
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Medline (MDLN) vs. Insulet (PODD): A comparison of their payout ratio against the Health Care Equipment & Services industry group benchmark.

Dividend Metrics

Dividend metrics for Medline (MDLN) and Insulet (PODD)
MetricMDLNPODD
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

P/E Ratio (TTM)

Insulet (PODD) at 23.94 is near its industry’s usual P/E ratio, while Medline (MDLN) at 90.09 sits above its peer range — an unusually expensive price for MDLN’s trailing earnings.

MDLN

Health Care Equipment & Services industry group

90.09

MDLN
90.09
Max
80.41
Q3
47.62
Median
29.93
Q1
21.19
Min
4.21

PODD

Health Care Equipment & Services industry group

23.94

Max
80.41
Q3
47.62
Median
29.93
PODD
23.94
Q1
21.19
Min
4.21
Loading chart…
Medline (MDLN) vs. Insulet (PODD): A comparison of their P/E ratio against the Health Care Equipment & Services industry group benchmark.

P/S Ratio (TTM)

On P/S ratio, both Medline (MDLN) at 1.70 and Insulet (PODD) at 3.19 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

MDLN

Health Care Equipment & Services industry group

1.70

Max
8.80
Q3
4.32
Median
2.13
MDLN
1.70
Q1
1.10
Min
0.03

PODD

Health Care Equipment & Services industry group

3.19

Max
8.80
Q3
4.32
PODD
3.19
Median
2.13
Q1
1.10
Min
0.03
Loading chart…
Medline (MDLN) vs. Insulet (PODD): A comparison of their P/S ratio against the Health Care Equipment & Services industry group benchmark.

P/B Ratio (MRQ)

Medline (MDLN) at 2.95 is valued about in line with its industry on P/B ratio, while Insulet (PODD) at 6.44 carries an above-peer premium to book — PODD is pricier on assets.

MDLN

Health Care Equipment & Services industry group

2.95

Max
11.68
Q3
6.12
Median
3.00
MDLN
2.95
Q1
1.73
Min
-1.31

PODD

Health Care Equipment & Services industry group

6.44

Max
11.68
PODD
6.44
Q3
6.12
Median
3.00
Q1
1.73
Min
-1.31
Loading chart…
Medline (MDLN) vs. Insulet (PODD): A comparison of their P/B ratio against the Health Care Equipment & Services industry group benchmark.

Valuation Metrics

Valuation metrics for Medline (MDLN) and Insulet (PODD)
MetricMDLNPODD
P/E Ratio (TTM)90.0923.94
P/S Ratio (TTM)1.703.19
P/B Ratio (MRQ)2.956.44
Free Cash Flow Yield (TTM)2.67%1.12%